Sodium Benzoate vs Sucralose: which is worse?

What is Sodium Benzoate?

Sodium benzoate is the sodium salt of benzoic acid (C7H5NaO2). In acidic foods and beverages, it converts to benzoic acid, which inhibits microbial growth. While benzoic acid occurs naturally in some fruits and spices at low levels, the commercial preservative is synthetically manufactured.

What is Sucralose?

Sucralose is a synthetic non-caloric sweetener made by selectively chlorinating three hydroxyl groups in sucrose (table sugar). Despite being derived from sugar, the chlorination makes it non-digestible: most passes through the body without being metabolized. It is approximately 600 times sweeter than sucrose.

Documented risks

Sodium Benzoate: Sodium benzoate's most significant documented concern is the benzene formation reaction. When sodium benzoate coexists with ascorbic acid (vitamin C) in acidic conditions, they react in the presence of metal ions (iron, copper) and UV light to produce benzene, an IARC Group 1 human carcinogen. FDA surveys in 2005-2007 found benzene exceeding the EPA drinking water standard (5 ppb) in 79 of 200 commercial beverages tested. This triggered voluntary reformulations across the beverage industry. The 2007 McCann et al. Lancet study showed that the combination of sodium benzoate with six artificial food dyes significantly increased hyperactivity in children — the effect was synergistic, with the combination producing greater behavioral effects than either ingredient alone. This finding led directly to the EU's mandatory warning label requirement for products combining sodium benzoate with specified dyes. A 2010 study in ADHD: Attention Deficit and Hyperactivity Disorders found associations between urinary sodium benzoate/hippuric acid metabolite levels and ADHD symptom severity in children, independent of dye exposure. A 2019 study in Nutrients (PMC6520673) found similar associations in Korean children. Mitochondrial DNA damage: Dr. Peter Piper at the University of Sheffield found that sodium benzoate at concentrations used in some beverages could damage mitochondrial DNA in yeast cells, potentially affecting mitochondrial function. These findings have not been fully replicated in human tissue studies. Hypersensitivity reactions including urticaria, angioedema, and contact dermatitis are documented. Cross-reactivity with aspirin has been reported in aspirin-sensitive individuals.

Sucralose: A 2023 study published in Nature Medicine found that sucralose-1,6-hexanediacid — a gut-derived metabolite of sucralose — enhanced T-cell immune activity in vitro. The researchers found that sucralose exposure in certain doses could potentially affect immune function. However, this was an early-stage study and its clinical implications for humans are not established. A 2021 Cell study found that sucralose and other non-nutritive sweeteners altered gut microbiome composition and glucose tolerance in human participants who were non-habitual sweetener users. The study found sucralose consumption was associated with glucose intolerance changes in some individuals, suggesting gut microbiome-mediated effects on metabolism. A 2016 study in the International Journal of Occupational and Environmental Health found sucralose consumption was associated with higher leukemia incidence in male mice at high lifetime doses. This finding prompted significant concern, though regulators noted the doses used far exceeded typical human intake. Chlorinated compounds: sucralose contains chlorine atoms in its structure. Critics have argued this makes it similar to organochlorine compounds, some of which are known carcinogens. Regulatory agencies have reviewed this and do not consider the chlorine in sucralose equivalent to organochlorine pollutants; the chlorinated positions are not metabolically active. However, high-temperature cooking with sucralose can generate chlorinated compounds. EFSA's 2017 re-evaluation concluded sucralose is safe and non-carcinogenic at its ADI of 15 mg/kg body weight. The FDA ADI of 5 mg/kg/day provides a substantial safety margin relative to typical consumer intake from Splenda use.